Norepinephrine 8mg in 0.9% Sodium Chloride 250 mL bag, Rx only, SCA Pharmaceuticals Windsor, CT 06095, NDC 70004-078-40
Published May 11, 2022 · Recall initiated: April 25, 2022
Summary
FDA records drug Class II recall D-0829-2022, published May 11, 2022 and initiated April 25, 2022. Recalling firm: SCA Pharmaceuticals; Status: Terminated; Reported quantity: 120 bags; Lot: Lot #: 1222035815, Exp. Date 10-Jul-22. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviations
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- SCA Pharmaceuticals
- Distributor
- Product was distributed nationwide within the United States
- Lot
- Lot #: 1222035815, Exp. Date 10-Jul-22
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAFentaNYL 500 mcg/250 mL - Bupivacaine HCl 0.1% in 0.9% Sodium Chloride 250mL Bag, Injection for Epidural UseAugust 2, 2023
- FDAOxytocin 30 units added to 0.9% Sodium Chloride 500 mL, Rx Only, Single Dose Container, SCA Pharmaceuticals,May 3, 2023
- FDAFentanyl 1,500 mcg/30 mL syringe, Injection for Intravenous Use, Concentration = 50 mcg/mL, Preservative Free,March 8, 2023
- FDAVancomycin HCl 1.5 g in 0.9% Sodium Chloride, 500 mL bags, Rx only, SCA Pharmaceuticals Windsor, CT 06095, NDCMay 11, 2022
- FDAFentanyl 2mcg/ml and Bupivacaine 0.125% in 0.9% Sodium Chloride 100 mL bags, Rx only, SCA PharmaceuticalsMay 11, 2022
- FDAEmpower Introducer Sheath with Hydrophilic Coating 21F x 56cm Model: 668782-100 (US)May 4, 2022
Questions about this recall
Was Norepinephrine 8mg in 0.9% Sodium Chloride 250 mL bag, Rx only, SCA Pharmaceuticals Windsor, CT 06095, NDC 70004-078-40 recalled?
Yes. FDA published recall D-0829-2022 on May 11, 2022. Reported hazard: CGMP Deviations
What should I do if I have this product?
Voluntary: Firm initiated · Letter